Yan Xiong1, Xuewen Wu2, Liqun Rao3. 1. College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 411107, China; College of Chemical Engineering, Xiangtan University, Xiangtan 411105, China. 2. College of Chemical Engineering, Xiangtan University, Xiangtan 411105, China. Electronic address: wxw@xtu.edu.cn. 3. College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 411107, China. Electronic address: raoliqun@163.com.
Abstract
AIM OF THE STUDY: Tetrastigma hemsleyanum (Sanyeqing) is traditionally used as a folk medicine for the treatment of cancer. However, the underlying mechanisms remain unclear. The purpose of this study was to investigate the possible mechanisms by which petroleum ether fraction (PEF) of Sanyeqing has anti-tumor activity on HeLa cells. METHODS: The chemical components of PEF were analyzed by gas chromatography-mass spectrometry. The cytotoxicity of PEF on HeLa cells was measured by MTT assay. Apoptosis was evaluated by phosphatidylserine translocation, mitochondrial membrane potential (Δψm) changes and the activation of caspase-3, caspase-8 and caspase-9. The levels in T-SOD, CAT, GSH-PX and MDA were measured. RESULTS: PEF of Sanyeqing inhibited the growth and induced apoptosis of HeLa cells in dose- and time-dependent manner. PEF triggered intrinsic apoptotic pathway indicated by the loss of mitochondrial membrane potential and the activation of caspase-9 and caspase-3. In addition, PEF activated extrinsic apoptotic pathway indicated by the activation of caspase-8. Furthermore, PEF decreased T-SOD, CAT, GSH-PX activities and increased MDA level. Chemical analysis revealed the presence of fatty acids and phytosterol in PEF. CONCLUSIONS: PEF of Tetrastigma hemsleyanum Diels et. Gilg (Sanyeqing) exhibits cytotoxic effects, triggers both extrinsic and intrinsic apoptotic pathways, and augments oxidative stress in cervical carcinoma HeLa cells. Sanyeqing has strong potential to be developed as an agent for the treatment of cervical cancer.
AIM OF THE STUDY: Tetrastigma hemsleyanum (Sanyeqing) is traditionally used as a folk medicine for the treatment of cancer. However, the underlying mechanisms remain unclear. The purpose of this study was to investigate the possible mechanisms by which petroleum ether fraction (PEF) of Sanyeqing has anti-tumor activity on HeLa cells. METHODS: The chemical components of PEF were analyzed by gas chromatography-mass spectrometry. The cytotoxicity of PEF on HeLa cells was measured by MTT assay. Apoptosis was evaluated by phosphatidylserine translocation, mitochondrial membrane potential (Δψm) changes and the activation of caspase-3, caspase-8 and caspase-9. The levels in T-SOD, CAT, GSH-PX and MDA were measured. RESULTS: PEF of Sanyeqing inhibited the growth and induced apoptosis of HeLa cells in dose- and time-dependent manner. PEF triggered intrinsic apoptotic pathway indicated by the loss of mitochondrial membrane potential and the activation of caspase-9 and caspase-3. In addition, PEF activated extrinsic apoptotic pathway indicated by the activation of caspase-8. Furthermore, PEF decreased T-SOD, CAT, GSH-PX activities and increased MDA level. Chemical analysis revealed the presence of fatty acids and phytosterol in PEF. CONCLUSIONS: PEF of Tetrastigma hemsleyanum Diels et. Gilg (Sanyeqing) exhibits cytotoxic effects, triggers both extrinsic and intrinsic apoptotic pathways, and augments oxidative stress in cervical carcinoma HeLa cells. Sanyeqing has strong potential to be developed as an agent for the treatment of cervical cancer.
Authors: K M Santos; I N F Gomes; R J Silva-Oliveira; F E Pinto; B G Oliveira; R C R Chagas; W Romão; R M V Reis; R I M A Ribeiro Journal: Biomed Res Int Date: 2018-03-25 Impact factor: 3.411
Authors: Cai Yi Wang; Hyun-Jae Jang; Yoo Kyong Han; Xiang Dong Su; Seung Woong Lee; Mun-Chual Rho; Heng-Shan Wang; Seo Young Yang; Young Ho Kim Journal: Molecules Date: 2018-06-14 Impact factor: 4.411
Authors: Tao Ji; Wei Wei Ji; Juan Wang; Hong Jiang Chen; Xin Peng; Ke Jun Cheng; Dan Qiu; Wei Jie Yang Journal: J Ethnopharmacol Date: 2020-08-12 Impact factor: 4.360